2 27 Abstract 28 Patients suffering from chronic lung diseases are abnormally colonized by many commensal and 29 pathogenic bacterial species among which Staphylococcus aureus is the most commonly identified 30 pathogen (prevalence in the lungs of cystic fibrosis (CF) patients greater than 70%). However, the 31 mechanisms underlying the adaptation of S. aureus to the lung are poorly understood.
We next searched for nonsynonymous mutations in the late isolates compared to cognate early 176 isolates and found four genes mutated in the late isolate of at least two patients (S4 Table) . These 177 four genes encode: i) SaeR, a regulator involved in the control of exoproteins expression, ii) the FakA 178 fatty acid kinase A, involved in biofilm formation [13] and virulence genes expression [37] , iii) the ThyA 179 thymidylate synthase, involved in pyrimidine metabolism whose inactivation confers SCV phenotype 180 and SXT resistance, and iv) the very large cell-wall associated fibronectin-binding protein Ebh. 181 182 189 The four pairs of isolates were harvested for proteomic analysis at post exponential growth phase.
190 Differences in the expression of proteins of each late isolate were analyzed and compared to their 249 Metabolite profiles comparisons. The difference in metabolic profiles between early and 250 late isolates of CP patients is highlighted by heatmaps shown in Fig S1B and Fig 3B. A list of 251 metabolites with altered amount in the four pairs of isolates is provided in S8 Table. 252 In CP1 patient, the metabolite profiling, which shows a marked reduction of citrate and cis-aconitate, 253 clearly indicates a reduced citric acid cycle activity. A drastic decrease in arginino-succinate is 254 observed and is in line with an increase of ArgF, ArgG and ArgH proteins found in proteomic analysis.
255 In CP2 patient, a drastic decrease in ornithine is probably caused by a diminution of ArcA protein 256 (arginine deiminase) found in proteomic analysis. Indeed, arginine fermentation into ornithine relies on 257 the arc operon. A severe reduction of threonine amounts was also recorded. In S. aureus, threonine is 258 synthesized from aspartate and serves itself as a precursor for the synthesis of the branched-chain 259 amino acid isoleucine. Of note, the threonine biosynthetic pathway has been shown to be essential for 
283
284 Functional characterization of the S. aureus isolates.
285
We first examined growth of the four pairs of isolates in broth (on solid media and in liquid culture; Fig   286 4 , Fig S2 and Fig S3) , determined their antibiotic susceptibility profiles and their capacity to form 287 biofilm (Fig S4 and Fig S5) .
288
Growth properties in broth. Colony morphology on brain heart infusion (BHI) agar plates 289 was similar to that of USA300-LAC or slightly smaller for all isolates, except for late isolates of CP2 290 and CP3 patients that displayed a typical SCV phenotype with very small colonies ( Fig S2) . CP2_late 291 and CP3_late isolates also failed to grow on Mueller-Hinton plates, suggesting that they had acquired 292 an auxotrophy for at least one of the compounds absent in the Mueller-Hinton agar medium, such as 293 thymidine, hemin, or menadione (that are present in BHI). Since thymidine-dependent SCVs have 294 been shown previously to be frequently isolated from the airways of CF patients [44], we first 295 monitored growth of the two SCV-like isolates in a defined medium mimicking the respiratory fluid of 296 cystic fibrosis patients (Cystic Fibrosis Sputum Medium or CFSM) [45] (Fig 4) . As anticipated, 297 CP2_late and CP3_late isolates exhibited a severe growth defect in the absence of thymidine whereas 298 supplementation with thymidine restored almost wild-type growth (i.e., similar to that recorded with 299 USA300-LAC, Fig 4B) . As previously mentioned and in line with these observations, genomic analysis 300 identified a mutation in the thyA gene for both isolates. Besides, CP4_late isolate displayed a 301 moderate reduced growth compared to USA300-LAC that was not corrected by adding thymidine in 302 the medium (not shown). As previously mentioned, genomic analysis of CP4_late isolate showed a 303 frameshit in panB gene, which is involved in de novo biosynthesis of pantothenic acid. Indeed, growth 304 of CP4_late isolate in the presence of pantothenate restored wild-type growth (Fig 4C) .
305
Antibiotic susceptibility. Antibiotic susceptibility assays showed that isolates of CP1 and 306 CP4 patients were resistant to methicillin, whereas isolates of CP2 and CP3 patients were methicillin 307 susceptible. Besides, the 2 SCV isolates (CP2_late and CP3_late) were resistant to SXT, which is 308 consistent with the fact that both patients received this antibiotic. A P48R mutation and a premature 310 supporting the thymidine auxotrophy and SXT resistance of these isolates.
311
Of note, the late isolate of CP4 patient acquired a resistance to fluoroquinolones, consistent with the 312 administration of ciprofloxacin to this patient. A F226S mutation, detected in gyrB gene in CP4_late 313 genome, could account for this fluoroquinolones resistance. The late isolate of CP3 patient acquired a 314 resistance to cyclines consistent with the administration of minocycline in this patient. A K57M amino 315 acid substitution in the ribosomal S10 gene was detected in CP3_late genome. Remarkably, two 316 clinical S. aureus isolates with mutation in this same region of the S10 protein (a deletion of residues 317 56 to 59; and double mutant K57M, Y58F) have been recently shown to confer resistance to tigecyclin
319
Biofilm formation. Bacteria often grow in organized communities known as biofilms, which 320 favor their persistence. Assuming that isolates retrieved from chronic infections might have a higher 321 biofilm-forming capacity than isolates retrieved from acute infections, we studied biofilm-forming 322 capacities of the four pairs of isolates. Remarkably, the eight clinical isolates displayed a greater 323 capacity to form biofilms, compared to USA300-LAC reference strain (p-value of <0.001, Fig S4) .
324 Furthermore, for three patients, the late isolates formed more biofilm than the early isolates, 325 suggesting that long-term adaptation had improved their biofilm formation capacity (p-value of <0.001, 326 Fig S5) .
328 S. aureus isolates exhibit an increased persistence within CFBE-F508del
329 epithelial cell line.
330 Numerous studies have shown that intracellular survival is likely to play an important role in long-term 331 infection [16] . Moreover, our results evidenced that most alterations found in coding sequences, 332 protein expression and metabolites impact metabolic pathways and especially amino-acids 333 metabolism, which suggests nutritional adaptation to a niche. We therefore thought to test if this 334 nutritional adaptation could favor intracellular persistence.
335
To evaluate the capacity of S. aureus isolates to persist intracellularly, we infected both bronchial 336 CFBE epithelial cell line 41o-(homozygous for the F508del-CFTR mutation) and CFBE with a plasmid 337 allowing wild type CFTR expression. We tested the 4 pairs of clinical isolates, the control strain 338 USA300-LAC and a stable SCV mutant altered in the haemin biosynthetic pathway (hereafter named 339 Δhem). The infection was pursued for 6 days, using gentamicin protection assay to prevent 340 extracellular bacterial growth, as previously described [20] . As expected, the number of wild-type 341 intracellular bacteria dramatically decreased during the course of infection whereas the Δhem mutant 342 was able to persist intracellularly during the whole course of the experiment (Fig S5) . Strikingly, at day 343 6 post-infection, all clinical isolates were able to persist at least 19-fold and up to 452-fold more than 344 the USA300-LAC reference strain (Fig 6) . For the 3 patients with cystic fibrosis, the late isolates 345 exhibited an improved ability to persist intracellularly within CFBE-F508del epithelial cells compared to 346 cognate early isolates at day 6 post-infection (Fig 6) . Of note, this was not observed for CP2, which is 347 not a CF patient. Interestingly, the two late isolates with thymidine auxotrophy (i.e., CP2 and CP3 late 348 isolates) had a reduced ability to persist within CFBE expressing wild type CFTR (CFBE-WT) epithelial 349 cells, whereas at day 6 post-infection, those thymidine auxotroph isolates persist better or equally well 350 than cognate early isolates within CFBE-F508del epithelial cells (Fig 6, Fig S6) . 
425
Prior infection assays, epithelial cells were seeded in uncoated wells for CFBE and wells coated 426 with collagen for HNE and all antibiotics were removed from culture medium. Epithelial cells were 457 for 120 min and then 40% to 80% of B in 1 min. At 125 min, the gradient was reversed to 5% to allow 458 re-equilibration of the column for 20 min before the next injection. One blank with two 30 minutes 459 linear gradients was run between triplicates to prevent sample carryover.
460
Peptides eluted from the column were analyzed by data dependent MS/MS, using the top-10 461 acquisition method. Briefly, the instrument settings were as follows: resolution was set to 70,000 for 462 MS scans and 17,500 for the data dependent MS/MS scans in order to increase speed. The MS AGC 463 target was set to 3.10 6 counts, whereas the MS/MS AGC target was set to 5. 
485
For accurate quantification, we analysed each isolate separately (3 samples from early and 3 486 samples from late collection). We filtered the data to keep only proteins with at least 3 valid values in 
535
For two-sample comparisons statistical significance was measured using unpaired two-tail 536 Student's t-test. For comparisons between more than two groups, statistical significance was 537 measured using one-way analysis of variance (ANOVA) with multiple comparisons (Dunnett's 538 correction) performed, with each value compared to that of the reference strain.
539
P values of <0.05 were considered to indicate statistical significance.
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Discussion
549
Our study revealed patient-specific adaptation, illustrated by the acquisition of mutations leading to 550 antibiotic resistances directly correlated to the drugs administered to the patient. Our study also 551 provided evidence for the acquisition of common adaptive traits, such as SCV phenotype, antibiotic 552 resistances, auxotrophies, reduced citric acid cycle activity, increased biofilm and intracellular 553 persistence abilities that occurred irrespective of the clone type.
554
Of particular interest, we report mutations in two master regulatory systems, Agr and Sae, likely to 555 impact multiple proteins expression and metabolites amounts. 
559
Genetic alterations directly or indirectly targeting SaeR regulon were identified in the 3 CF patients.
560 Since SaeR is involved in the regulation of over 20 virulence factor genes [65] and SaeRS-deficient 561 bacteria are less infective in animal models [66] , it is likely that long-term colonization is associated to 562 reduced virulence.
563
In CP1, CP3 and CP4 late isolates, we observed an increased in the expression of the SdrD 564 adhesin belonging to the SaeR regulon [67] (S7 Table) , suggesting that SdrD is also important for 565 long-term lung colonization. Of note, SdrD is involved in adhesion to human nasal epithelial cells and 566 to human keratinocytes [68].
567
In patients with chronic lung infections, SCVs detection is most often the consequence of a long- 
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Other striking traits of phenotypic convergent evolution of S. aureus identified in this work were the 581 increased ability to form biofilm and to persist in the intracellular niche. For CP3 and CP4 patients, the 582 increased biofilm ability of CP3 and CP4 late isolates could be linked to a mutation in the fakA gene, 583 encoding fatty acid kinase A (FakA). Indeed, several studies showed that FakA-null strains were 584 proficient in biofilm formation [13] and deficient in the expression of virulence factors controlled by the 585 SaeRS system [37] . Overexpression of adhesins detected in proteomic analysis could also ultimately 586 lead to increase biofilm formation in tested clinical isolates.
587
Although S. aureus is generally not considered as an intracellular pathogen, numerous studies 588 have demonstrated its ability to persist within host cells [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . Strikingly, all the clinical isolates 589 exhibited a greater ability to persist within CFBE-F508del epithelial cells compared to the USA300-590 LAC reference strain (Fig S6) . Moreover, for the three CF patients, the S. aureus late isolates showed 591 a greater ability to persist within CFBE-F508del epithelial cells compared to the early ones at day 6 592 post-infection. Of note, the late isolate of CP2 did not present an improved ability to persist 593 intracellularly within CFBE-F508del epithelial cells possibly due the fact that it has adapted to a non-594 CF patient.
596
Conclusions 597
Our multi-omics approach allowed both confirmation of previously known mechanisms and 598 identification of novel candidate genes and pathways involved in the persistence ability of clinical 599 isolates. We now provide evidence that the saeR/fakA regulon and the pantothenate pathway could 600 also be promising therapeutic targets to fight persistent S. aureus infections.
601
Our study suggests that the use of antibiotic with a good intracellular penetration should be the 602 best therapeutic option in order to eradicate S. aureus from chronically infected lungs. 
